Page last updated: 2024-10-24

carmustine and Aseptic Necrosis of Femur Head

carmustine has been researched along with Aseptic Necrosis of Femur Head in 1 studies

Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kempin, S1
Lee, BJ1
Thaler, HT1
Koziner, B1
Hecht, S1
Gee, T1
Arlin, Z1
Little, C1
Straus, D1
Reich, L1
Phillips, E1
Al-Mondhiry, H1
Dowling, M1
Mayer, K1
Clarkson, B1

Reviews

1 review available for carmustine and Aseptic Necrosis of Femur Head

ArticleYear
Combination chemotherapy of advanced chronic lymphocytic leukemia: the M-2 protocol (vincristine, BCNU, cyclophosphamide, melphalan, and prednisone).
    Blood, 1982, Volume: 60, Issue:5

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide;

1982